M B Stein

Summary

Affiliation: University of California
Country: USA

Publications

  1. request reprint
    Stein M, Sareen J, Hami S, Chao J. Pindolol potentiation of paroxetine for generalized social phobia: a double-blind, placebo-controlled, crossover study. Am J Psychiatry. 2001;158:1725-7 pubmed
    ..The effectiveness of pindolol as an adjunctive treatment to boost response to selective serotonin reuptake inhibitors (SSRIs) in patients with generalized social phobia was tested...
  2. request reprint
    Stein M, Barrett Connor E. Quality of life in older adults receiving medications for anxiety, depression, or insomnia: findings from a community-based study. Am J Geriatr Psychiatry. 2002;10:568-74 pubmed
    ..The authors examined the association between these conditions, as indicated by the use of antidepressant, anxiolytic, or hypnotic medications, and HRQoL parameters in older men and women...
  3. request reprint
    Stein M, Schork N, Gelernter J. Gene-by-environment (serotonin transporter and childhood maltreatment) interaction for anxiety sensitivity, an intermediate phenotype for anxiety disorders. Neuropsychopharmacology. 2008;33:312-9 pubmed
    ..These findings are consistent with the notion that 5-HTTLPR operates broadly to moderate emotional responsivity to stress. ..
  4. Stein M, Yang B, Chavira D, Hitchcock C, Sung S, Shipon Blum E, et al. A common genetic variant in the neurexin superfamily member CNTNAP2 is associated with increased risk for selective mutism and social anxiety-related traits. Biol Psychiatry. 2011;69:825-31 pubmed publisher
    ..We examined association of a susceptibility gene, contactin-associated protein-like 2 (CNTNAP2), for ASDs and specific language impairment with SM and social anxiety-related traits...
  5. Yue J, Burke J, Upadhyayula P, Winkler E, Deng H, Robinson C, et al. Selective Serotonin Reuptake Inhibitors for Treating Neurocognitive and Neuropsychiatric Disorders Following Traumatic Brain Injury: An Evaluation of Current Evidence. Brain Sci. 2017;7: pubmed publisher
    ..Furthermore, placebo-controlled studies with extended follow-up periods and concurrent biomarker, neuroimaging and behavioral data are necessary to delineate the attributable pharmacological effects of SSRIs in the TBI population. ..

Detail Information

Publications5

  1. request reprint
    Stein M, Sareen J, Hami S, Chao J. Pindolol potentiation of paroxetine for generalized social phobia: a double-blind, placebo-controlled, crossover study. Am J Psychiatry. 2001;158:1725-7 pubmed
    ..The effectiveness of pindolol as an adjunctive treatment to boost response to selective serotonin reuptake inhibitors (SSRIs) in patients with generalized social phobia was tested...
  2. request reprint
    Stein M, Barrett Connor E. Quality of life in older adults receiving medications for anxiety, depression, or insomnia: findings from a community-based study. Am J Geriatr Psychiatry. 2002;10:568-74 pubmed
    ..The authors examined the association between these conditions, as indicated by the use of antidepressant, anxiolytic, or hypnotic medications, and HRQoL parameters in older men and women...
  3. request reprint
    Stein M, Schork N, Gelernter J. Gene-by-environment (serotonin transporter and childhood maltreatment) interaction for anxiety sensitivity, an intermediate phenotype for anxiety disorders. Neuropsychopharmacology. 2008;33:312-9 pubmed
    ..These findings are consistent with the notion that 5-HTTLPR operates broadly to moderate emotional responsivity to stress. ..
  4. Stein M, Yang B, Chavira D, Hitchcock C, Sung S, Shipon Blum E, et al. A common genetic variant in the neurexin superfamily member CNTNAP2 is associated with increased risk for selective mutism and social anxiety-related traits. Biol Psychiatry. 2011;69:825-31 pubmed publisher
    ..We examined association of a susceptibility gene, contactin-associated protein-like 2 (CNTNAP2), for ASDs and specific language impairment with SM and social anxiety-related traits...
  5. Yue J, Burke J, Upadhyayula P, Winkler E, Deng H, Robinson C, et al. Selective Serotonin Reuptake Inhibitors for Treating Neurocognitive and Neuropsychiatric Disorders Following Traumatic Brain Injury: An Evaluation of Current Evidence. Brain Sci. 2017;7: pubmed publisher
    ..Furthermore, placebo-controlled studies with extended follow-up periods and concurrent biomarker, neuroimaging and behavioral data are necessary to delineate the attributable pharmacological effects of SSRIs in the TBI population. ..